Protein
Design Labs About
Protein Design Labs Protein
Design Labs, Inc. discovers and develops humanized monoclonal antibodies for the
treatment of disease, particularly inflammatory bowel disease and cancer. Protein
Design has seven marketed antibody products already licensed under their humanization
patents and at least 40 additional humanized antibodies in clinical trials. PRODUCT
DEVELOPMENT --PIPELINE --PDL's product development programs focus
on therapeutic antibodies for autoimmune
and inflammatory
conditions, asthma
and cancer.
Daclizumab --Asthma,
Multiple
Sclerosis Nuvion® --Ulcerative Colitis HuZAF™ (Anti-Gamma Interferon)
--Crohn's
Disease Anti-a5ß1 Integrin --Solid Tumors More
on
Protein Design
Basic Chart
for Protein Design